------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Immunex Corp. said its scientists isolated a molecule which may hold potential as a treatment for disruptions of the
    immune-system, ranging from organ-transplant rejection, to allergies and asthma.

Treebanked sentence:
--------------------
    Immunex Corp. said 0 its scientists isolated a molecule which *T*-1 may hold potential as a treatment for disruptions of
    the immune - system , ranging from organ - transplant rejection , to allergies and asthma .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Immunex)
                    (NNP Corp.))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (PRP$ its)
                                 (NNS scientists))
                         (VP (VBD isolated)
                             (NP (NP (DT a)
                                     (NN molecule))
                                 (SBAR (WHNP-1 (WDT which))
                                       (S (NP-SBJ (-NONE- *T*-1))
                                          (VP (MD may)
                                              (VP (VB hold)
                                                  (NP (NP (JJ potential))
                                                      (PP (IN as)
                                                          (NP (NP (DT a)
                                                                  (NN treatment))
                                                              (PP (IN for)
                                                                  (NP (NP (NP (NNS disruptions))
                                                                          (PP (IN of)
                                                                              (NP (DT the)
                                                                                  (NN immune)
                                                                                  (HYPH -)
                                                                                  (NN system))))
                                                                      (, ,)
                                                                      (VP (VBG ranging)
                                                                          (PP-DIR (IN from)
                                                                                  (NP (NML (NN organ)
                                                                                           (HYPH -)
                                                                                           (NN transplant))
                                                                                      (NN rejection))
                                                                                  (, ,))
                                                                          (PP-DIR (IN to)
                                                                                  (NP (NNS allergies)
                                                                                      (CC and)
                                                                                      (NN asthma))))))))))))))))))
            (. .)))

Leaves:
-------
    0   Immunex
           coref: IDENT        16    0-1    Immunex Corp.
           name:  ORG                0-1    Immunex Corp.
    1   Corp.
    2   said
           sense: say-v.1
           prop:  say.01
            v          * -> 2:0,  said
            ARG0       * -> 0:1,  Immunex Corp.
            ARG1       * -> 3:1,  0 its scientists isolated a molecule which *T*-1 may hold potential as a treatment for
                                  disruptions of the immune - system , ranging from organ - transplant rejection , to
                                  allergies and asthma
    3   0
    4   its
           coref: IDENT        16    4-4    its
    5   scientists
    6   isolated
           sense: isolate-v.2
           prop:  isolate.01
            v          * -> 6:0,  isolated
            ARG0       * -> 4:1,  its scientists
            ARG1       * -> 7:2,  a molecule which *T*-1 may hold potential as a treatment for disruptions of the immune
                                  - system , ranging from organ - transplant rejection , to allergies and asthma
    7   a
           coref: IDENT        19    7-35   a molecule which *T*-1 may hold potential as a treatment for disruptions
                                            of the immune - system , ranging from organ - transplant rejection , to
                                            allergies and asthma
    8   molecule
    9   which
    10  *T*-1
    11  may
    12  hold
           sense: hold-v.5
           prop:  hold.01
            v          * -> 12:0, hold
            ARG0       * -> 10:0, *T*-1 -> 9:1, which
            ARGM-MOD   * -> 11:0, may
            ARG1       * -> 13:2, potential as a treatment for disruptions of the immune - system , ranging from organ -
                                  transplant rejection , to allergies and asthma
            LINK-SLC   * -> 7:1,  a molecule
                       * -> 10:0, *T*-1 -> 9:1, which
    13  potential
    14  as
    15  a
    16  treatment
           sense: treatment-n.1
    17  for
    18  disruptions
    19  of
    20  the
    21  immune
    22  -
    23  system
    24  ,
    25  ranging
           sense: range-v.1
           prop:  range.01
            v          * -> 25:0, ranging
            ARG1       * -> 18:2, disruptions of the immune - system
            ARG3       * -> 26:1, from organ - transplant rejection ,
            ARG4       * -> 32:1, to allergies and asthma
    26  from
    27  organ
    28  -
    29  transplant
    30  rejection
           sense: rejection-n.2
    31  ,
    32  to
    33  allergies
    34  and
    35  asthma
    36  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The molecule is the mouse version of a protein called the interleukin-4 receptor.

Treebanked sentence:
--------------------
    The molecule is the mouse version of a protein called * *PRO*-5 the interleukin - 4 receptor .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NN molecule))
            (VP (VBZ is)
                (NP-PRD (NP (DT the)
                            (NN mouse)
                            (NN version))
                        (PP (IN of)
                            (NP (NP (DT a)
                                    (NN protein))
                                (VP (VBN called)
                                    (NP-5 (-NONE- *))
                                    (S-CLR (NP-SBJ (-NONE- *PRO*-5))
                                           (NP-PRD (DT the)
                                                   (NML (NN interleukin)
                                                        (HYPH -)
                                                        (CD 4))
                                                   (NN receptor))))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        19    0-1    The molecule
    1   molecule
    2   is
           sense: be-v.1
           prop:  be.01
            v          * -> 2:0,  is
            ARG1       * -> 0:1,  The molecule
            ARG2       * -> 3:2,  the mouse version of a protein called * *PRO*-5 the interleukin - 4 receptor
    3   the
    4   mouse
    5   version
           sense: version-n.2
    6   of
    7   a
           coref: IDENT        20    7-16   a protein called * *PRO*-5 the interleukin - 4 receptor
    8   protein
    9   called
           sense: call-v.5
           prop:  call.01
            v          * -> 9:0,  called
            ARG1       * -> 10:0, *
            ARG2       * -> 12:1, the interleukin - 4 receptor
            LINK-PCR   * -> 7:1,  a protein
                       * -> 10:0, *
    10  *
    11  *PRO*-5
    12  the
    13  interleukin
    14  -
    15  4
    16  receptor
    17  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    IL-4 is a hormone which directs the growth and function of white blood cells involved in the body's immune response.

Treebanked sentence:
--------------------
    IL - 4 is a hormone which *T*-5 directs the growth and function of white blood cells involved * in the body 's immune
    response .

Tree:
-----
    (TOP (S (NP-SBJ (NN IL)
                    (HYPH -)
                    (CD 4))
            (VP (VBZ is)
                (NP-PRD (NP (DT a)
                            (NN hormone))
                        (SBAR (WHNP-5 (WDT which))
                              (S (NP-SBJ (-NONE- *T*-5))
                                 (VP (VBZ directs)
                                     (NP (NP (DT the)
                                             (NN growth)
                                             (CC and)
                                             (NN function))
                                         (PP (IN of)
                                             (NP (NP (JJ white)
                                                     (NN blood)
                                                     (NNS cells))
                                                 (VP (VBN involved)
                                                     (NP (-NONE- *))
                                                     (PP-CLR (IN in)
                                                             (NP (NP (DT the)
                                                                     (NN body)
                                                                     (POS 's))
                                                                 (JJ immune)
                                                                 (NN response))))))))))))
            (. .)))

Leaves:
-------
    0   IL
           coref: IDENT        21    0-2    IL - 4
    1   -
    2   4
    3   is
           sense: be-v.2
           prop:  be.01
            v          * -> 3:0,  is
            ARG1       * -> 0:1,  IL - 4
            ARG2       * -> 4:2,  a hormone which *T*-5 directs the growth and function of white blood cells involved *
                                  in the body 's immune response
    4   a
    5   hormone
    6   which
    7   *T*-5
    8   directs
           sense: direct-v.1
           prop:  direct.01
            v          * -> 8:0,  directs
            ARG0       * -> 7:0,  *T*-5 -> 6:1, which
            ARG1       * -> 9:2,  the growth and function of white blood cells involved * in the body 's immune response
            LINK-SLC   * -> 4:1,  a hormone
                       * -> 7:0,  *T*-5 -> 6:1, which
    9   the
    10  growth
           sense: growth-n.1
    11  and
    12  function
           sense: function-n.6
           prop:  function.01
            n          * -> 12:0, function
            ARG0       * -> 13:1, of white blood cells involved * in the body 's immune response
    13  of
    14  white
    15  blood
    16  cells
           sense: cell-n.1
    17  involved
           sense: involve-v.1
           prop:  involve.01
            v          * -> 17:0, involved
            ARG1       * -> 18:0, *
            ARG2       * -> 19:1, in the body 's immune response
            LINK-PCR   * -> 14:1, white blood cells
                       * -> 18:0, *
    18  *
    19  in
    20  the
    21  body
           sense: body-n.2
    22  's
    23  immune
    24  response
           sense: response-n.2
           prop:  response.01
            n          * -> 24:0, response
            ARG0       * -> 20:1, the body 's
            ARG2       * -> 23:0, immune
    25  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The IL-4 receptor on the surface of such cells receives the hormone's message to rally the body's defense.

Treebanked sentence:
--------------------
    The IL - 4 receptor on the surface of such cells receives the hormone 's message *PRO* to rally the body 's defense .

Tree:
-----
    (TOP (S (NP-SBJ (NP (DT The)
                        (NML (NN IL)
                             (HYPH -)
                             (CD 4))
                        (NN receptor))
                    (PP-LOC (IN on)
                            (NP (NP (DT the)
                                    (NN surface))
                                (PP (IN of)
                                    (NP (JJ such)
                                        (NNS cells))))))
            (VP (VBZ receives)
                (NP (NP (DT the)
                        (NN hormone)
                        (POS 's))
                    (NN message)
                    (S (NP-SBJ (-NONE- *PRO*))
                       (VP (TO to)
                           (VP (VB rally)
                               (NP (NP (DT the)
                                       (NN body)
                                       (POS 's))
                                   (NN defense)))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        20    0-10   The IL - 4 receptor on the surface of such cells
    1   IL
           coref: IDENT        21    1-3    IL - 4
    2   -
    3   4
    4   receptor
    5   on
    6   the
    7   surface
    8   of
    9   such
    10  cells
           sense: cell-n.1
    11  receives
           sense: receive-v.1
           prop:  receive.01
            v          * -> 11:0, receives
            ARG0       * -> 0:2,  The IL - 4 receptor on the surface of such cells
            ARG1       * -> 12:2, the hormone 's message *PRO* to rally the body 's defense
    12  the
           coref: IDENT        21    12-14  the hormone 's
    13  hormone
    14  's
    15  message
           sense: message-n.1
    16  *PRO*
    17  to
    18  rally
           sense: rally-v.1
           prop:  rally.01
            v          * -> 18:0, rally
            ARG0       * -> 16:0, *PRO*
            ARG1       * -> 19:2, the body 's defense
    19  the
    20  body
           sense: body-n.2
    21  's
    22  defense
           sense: defense-n.5
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But in certain conditions such as autoimmune diseases and allergies and transplant rejection, doctors would like to damp
    the immune response so such cells do n't touch off harmful inflammatory reactions or cell destruction.

Treebanked sentence:
--------------------
    But in certain conditions such as autoimmune diseases and allergies and transplant rejection , doctors would like
    *PRO*-1 to damp the immune response so such cells do n't touch off harmful inflammatory reactions or cell destruction .

Tree:
-----
    (TOP (S (CC But)
            (PP (IN in)
                (NP (NP (JJ certain)
                        (NNS conditions))
                    (PP (JJ such)
                        (IN as)
                        (NP (NP (JJ autoimmune)
                                (NNS diseases))
                            (CC and)
                            (NP (NNS allergies))
                            (CC and)
                            (NP (NN transplant)
                                (NN rejection))))))
            (, ,)
            (NP-SBJ-1 (NNS doctors))
            (VP (MD would)
                (VP (VB like)
                    (S (NP-SBJ (-NONE- *PRO*-1))
                       (VP (TO to)
                           (VP (VB damp)
                               (NP (DT the)
                                   (JJ immune)
                                   (NN response))
                               (SBAR-PRP (IN so)
                                         (S (NP-SBJ (JJ such)
                                                    (NNS cells))
                                            (VP (VBP do)
                                                (RB n't)
                                                (VP (VB touch)
                                                    (PRT (RP off))
                                                    (NP (NP (JJ harmful)
                                                            (JJ inflammatory)
                                                            (NNS reactions))
                                                        (CC or)
                                                        (NP (NN cell)
                                                            (NN destruction))))))))))))
            (. .)))

Leaves:
-------
    0   But
    1   in
    2   certain
    3   conditions
           sense: condition-n.1
    4   such
    5   as
    6   autoimmune
    7   diseases
    8   and
    9   allergies
    10  and
    11  transplant
    12  rejection
           sense: rejection-n.2
    13  ,
    14  doctors
    15  would
    16  like
           sense: like-v.1
           prop:  like.02
            v          * -> 16:0, like
            ARGM-ADV   * -> 1:1,  in certain conditions such as autoimmune diseases and allergies and transplant
                                  rejection
            ARG0       * -> 14:1, doctors
            ARGM-MOD   * -> 15:0, would
            ARG1       * -> 17:2, *PRO*-1 to damp the immune response so such cells do n't touch off harmful
                                  inflammatory reactions or cell destruction
    17  *PRO*-1
    18  to
    19  damp
           sense: damp-v.1
           prop:  damp.01
            v          * -> 19:0, damp
            ARG0       * -> 17:0, *PRO*-1 -> 14:1, doctors
            ARG1       * -> 20:1, the immune response
            ARGM-PNC   * -> 23:1, so such cells do n't touch off harmful inflammatory reactions or cell destruction
    20  the
    21  immune
    22  response
           sense: response-n.2
           prop:  response.01
            n          * -> 22:0, response
            ARG2       * -> 21:0, immune
    23  so
    24  such
    25  cells
           sense: cell-n.1
    26  do
    27  n't
    28  touch
           sense: touch-v.9
           prop:  touch.02
            v          * -> 28:0, touch
                         -> 29:1, off
            ARG0       * -> 24:1, such cells
            ARGM-NEG   * -> 27:0, n't
            ARG1       * -> 30:2, harmful inflammatory reactions or cell destruction
    29  off
    30  harmful
    31  inflammatory
    32  reactions
    33  or
    34  cell
           sense: cell-n.1
    35  destruction
    36  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    A soluble form of the receptor might turn off a specific part of the immune response without general immune suppression,
    the company said.

Treebanked sentence:
--------------------
    A soluble form of the receptor might turn off a specific part of the immune response without general immune suppression
    , the company said 0 *T*-1 .

Tree:
-----
    (TOP (S (S-TPC-1 (NP-SBJ (NP (DT A)
                                 (JJ soluble)
                                 (NN form))
                             (PP (IN of)
                                 (NP (DT the)
                                     (NN receptor))))
                     (VP (MD might)
                         (VP (VB turn)
                             (PRT (RP off))
                             (NP (NP (DT a)
                                     (JJ specific)
                                     (NN part))
                                 (PP (IN of)
                                     (NP (DT the)
                                         (JJ immune)
                                         (NN response))))
                             (PP (IN without)
                                 (NP (JJ general)
                                     (JJ immune)
                                     (NN suppression))))))
            (, ,)
            (NP-SBJ (DT the)
                    (NN company))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-1))))
            (. .)))

Leaves:
-------
    0   A
    1   soluble
    2   form
           sense: form-n.4
    3   of
    4   the
           coref: IDENT        20    4-5    the receptor
    5   receptor
    6   might
    7   turn
           sense: turn-v.5
           prop:  turn.07
            v          * -> 7:0,  turn
                         -> 8:1,  off
            ARG0       * -> 0:2,  A soluble form of the receptor
            ARGM-MOD   * -> 6:0,  might
            ARG1       * -> 9:2,  a specific part of the immune response
            ARGM-MNR   * -> 16:1, without general immune suppression
    8   off
    9   a
    10  specific
    11  part
           sense: part-n.1
    12  of
    13  the
    14  immune
    15  response
           sense: response-n.2
           prop:  response.01
            n          * -> 15:0, response
            ARG2       * -> 14:0, immune
    16  without
    17  general
    18  immune
    19  suppression
    20  ,
    21  the
           coref: IDENT        16    21-22  the company
    22  company
           sense: company-n.1
    23  said
           sense: say-v.1
           prop:  say.01
            v          * -> 23:0, said
            ARG1       * -> 25:0, *T*-1 -> 0:3, A soluble form of the receptor might turn off a specific part of the
                                                immune response without general immune suppression
            ARG0       * -> 21:1, the company
    24  0
    25  *T*-1
    26  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The IL-4 receptor is one of five such receptors to be developed and tested by Receptech Corp., a spinoff of Immunex,
    through a proposed $ 30 million initial public offering.

Treebanked sentence:
--------------------
    The IL - 4 receptor is one of five such receptors 0 *T*-2 to be *-3 developed and tested by Receptech Corp. , a spinoff
    of Immunex , through a proposed $ 30 million *U* initial public offering .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NML (NN IL)
                         (HYPH -)
                         (CD 4))
                    (NN receptor))
            (VP (VBZ is)
                (NP-PRD (NP (CD one))
                        (PP (IN of)
                            (NP (NP (CD five)
                                    (JJ such)
                                    (NNS receptors))
                                (SBAR (WHNP-2 (-NONE- 0))
                                      (S (NP-SBJ-3 (-NONE- *T*-2))
                                         (VP (TO to)
                                             (VP (VB be)
                                                 (NP (-NONE- *-3))
                                                 (VP (VBN developed)
                                                     (CC and)
                                                     (VBN tested)
                                                     (PP (IN by)
                                                         (NP-LGS (NP (NNP Receptech)
                                                                     (NNP Corp.))
                                                                 (, ,)
                                                                 (NP (NP (DT a)
                                                                         (NN spinoff))
                                                                     (PP (IN of)
                                                                         (NP (NNP Immunex))))))
                                                     (, ,)
                                                     (PP-MNR (IN through)
                                                             (NP (DT a)
                                                                 (VBN proposed)
                                                                 (NML (QP ($ $)
                                                                          (CD 30)
                                                                          (CD million))
                                                                      (-NONE- *U*))
                                                                 (JJ initial)
                                                                 (JJ public)
                                                                 (NN offering))))))))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        20    0-4    The IL - 4 receptor
    1   IL
           coref: IDENT        21    1-3    IL - 4
    2   -
    3   4
    4   receptor
    5   is
           sense: be-v.2
           prop:  be.01
            v          * -> 5:0,  is
            ARG1       * -> 0:1,  The IL - 4 receptor
            ARG2       * -> 6:2,  one of five such receptors 0 *T*-2 to be *-3 developed and tested by Receptech Corp. ,
                                  a spinoff of Immunex , through a proposed $ 30 million *U* initial public offering
    6   one
           name:  CARDINAL           6-6    one
    7   of
    8   five
           coref: IDENT        22    8-37   five such receptors 0 *T*-2 to be *-3 developed and tested by Receptech
                                            Corp. , a spinoff of Immunex , through a proposed $ 30 million *U* initial
                                            public offering
           name:  CARDINAL           8-8    five
    9   such
    10  receptors
    11  0
    12  *T*-2
    13  to
    14  be
           prop:  be.03
            v          * -> 14:0, be
    15  *-3
    16  developed
           sense: develop-v.1
           prop:  develop.02
            v          * -> 16:0, developed
            ARG1       * -> 15:0, *-3 -> 12:0, *T*-2 -> 11:0, 0
            ARG0       * -> 19:1, by Receptech Corp. , a spinoff of Immunex
            LINK-PCR   * -> 8:1,  five such receptors
                       * -> 11:0, 0
                       * -> 12:0, *T*-2 -> 11:0, 0
                       * -> 15:0, *-3 -> 12:0, *T*-2 -> 11:0, 0
    17  and
    18  tested
           sense: test-v.1
           prop:  test.01
            v          * -> 18:0, tested
            ARG1       * -> 15:0, *-3 -> 12:0, *T*-2 -> 11:0, 0
            ARG0       * -> 19:1, by Receptech Corp. , a spinoff of Immunex
            ARGM-MNR   * -> 28:1, through a proposed $ 30 million *U* initial public offering
            LINK-PCR   * -> 8:1,  five such receptors
                       * -> 11:0, 0
                       * -> 12:0, *T*-2 -> 11:0, 0
                       * -> 15:0, *-3 -> 12:0, *T*-2 -> 11:0, 0
    19  by
    20  Receptech
           coref: APPOS HEAD   18    20-21  Receptech Corp.
           coref: IDENT        17    20-26  Receptech Corp. , a spinoff of Immunex
           name:  ORG                20-21  Receptech Corp.
    21  Corp.
    22  ,
    23  a
           coref: APPOS ATTRIB 18    23-26  a spinoff of Immunex
    24  spinoff
    25  of
    26  Immunex
           coref: IDENT        16    26-26  Immunex
           name:  ORG                26-26  Immunex
    27  ,
    28  through
    29  a
    30  proposed
           sense: propose-v.1
           prop:  propose.01
            v          * -> 30:0, proposed
            ARG1       * -> 37:0, offering
    31  $
           name:  MONEY              31-33  $ 30 million
    32  30
    33  million
    34  *U*
    35  initial
    36  public
    37  offering
           sense: offering-n.1
           prop:  offering.01
            n          * -> 37:0, offering
            ARG2       * -> 31:2, $ 30 million *U*
            ARGM-TMP   * -> 35:0, initial
            ARG3       * -> 36:0, public
    38  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Immunex will contract with the spinoff to provide the research, development and initial testing of the new agents.

Treebanked sentence:
--------------------
    Immunex will contract with the spinoff *PRO*-1 to provide the research , development and initial testing of the new
    agents .

Tree:
-----
    (TOP (S (NP-SBJ-1 (NNP Immunex))
            (VP (MD will)
                (VP (VB contract)
                    (PP-CLR (IN with)
                            (NP (DT the)
                                (NN spinoff)))
                    (S-PRP (NP-SBJ (-NONE- *PRO*-1))
                           (VP (TO to)
                               (VP (VB provide)
                                   (NP (NP (DT the)
                                           (NN research))
                                       (, ,)
                                       (NP (NN development))
                                       (CC and)
                                       (NP (NP (JJ initial)
                                               (NN testing))
                                           (PP (IN of)
                                               (NP (DT the)
                                                   (JJ new)
                                                   (NNS agents))))))))))
            (. .)))

Leaves:
-------
    0   Immunex
           coref: IDENT        16    0-0    Immunex
           name:  ORG                0-0    Immunex
    1   will
    2   contract
           sense: contract-v.1
           prop:  contract.02
            v          * -> 2:0,  contract
            ARG0       * -> 0:1,  Immunex
            ARGM-MOD   * -> 1:0,  will
            ARG2       * -> 3:1,  with the spinoff
            ARG1       * -> 6:2,  *PRO*-1 to provide the research , development and initial testing of the new agents
    3   with
    4   the
           coref: IDENT        17    4-5    the spinoff
    5   spinoff
    6   *PRO*-1
    7   to
    8   provide
           sense: provide-v.1
           prop:  provide.01
            v          * -> 8:0,  provide
            ARG0       * -> 6:0,  *PRO*-1 -> 0:1, Immunex
            ARG1       * -> 9:2,  the research , development and initial testing of the new agents
    9   the
    10  research
           sense: research-n.1
    11  ,
    12  development
           sense: development-n.1
           prop:  development.02
            n          * -> 12:0, development
    13  and
    14  initial
    15  testing
           sense: test-n.1
    16  of
    17  the
           coref: IDENT        22    17-19  the new agents
    18  new
    19  agents
           sense: agent-n.1
    20  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Immunex will have the option to buy back Receptech shares after five years.

Treebanked sentence:
--------------------
    Immunex will have the option *PRO* to buy back Receptech shares after five years .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Immunex))
            (VP (MD will)
                (VP (VB have)
                    (NP (DT the)
                        (NN option)
                        (S (NP-SBJ (-NONE- *PRO*))
                           (VP (TO to)
                               (VP (VB buy)
                                   (PRT (RP back))
                                   (NP (NNP Receptech)
                                       (NNS shares))
                                   (PP-TMP (IN after)
                                           (NP (CD five)
                                               (NNS years)))))))))
            (. .)))

Leaves:
-------
    0   Immunex
           coref: IDENT        16    0-0    Immunex
           name:  ORG                0-0    Immunex
    1   will
    2   have
           sense: have-v.2
           prop:  have.03
            v          * -> 2:0,  have
            ARG0       * -> 0:1,  Immunex
            ARGM-MOD   * -> 1:0,  will
            ARG1       * -> 3:1,  the option *PRO* to buy back Receptech shares after five years
    3   the
    4   option
           sense: option-n.2
    5   *PRO*
    6   to
    7   buy
           sense: buy-v.1
           prop:  buy.01
            v          * -> 7:0,  buy
            ARG0       * -> 5:0,  *PRO*
            ARGM-DIR   * -> 8:1,  back
            ARG1       * -> 9:1,  Receptech shares
            ARGM-TMP   * -> 11:1, after five years
            LINK-PCR   * -> 0:1,  Immunex
                       * -> 5:0,  *PRO*
    8   back
    9   Receptech
           coref: IDENT        17    9-9    Receptech
           name:  ORG                9-9    Receptech
    10  shares
           sense: share-n.2
    11  after
    12  five
           name:  DATE               12-13  five years
    13  years
    14  .


========================================================================================================================
Coreference chains for section 0:
---------------------------------

    Chain 16 (IDENT)
               0.0-1      Immunex Corp.
               0.4-4      its
               5.21-22    the company
               6.26-26    Immunex
               7.0-0      Immunex
               8.0-0      Immunex

    Chain 19 (IDENT)
               0.7-35     a molecule which *T*-1 may hold potential as a treatment for disruptions of the immune -
                          system , ranging from organ - transplant rejection , to allergies and asthma
               1.0-1      The molecule

    Chain 20 (IDENT)
               1.7-16     a protein called * *PRO*-5 the interleukin - 4 receptor
               3.0-10     The IL - 4 receptor on the surface of such cells
               5.4-5      the receptor
               6.0-4      The IL - 4 receptor

    Chain 21 (IDENT)
               2.0-2      IL - 4
               3.1-3      IL - 4
               3.12-14    the hormone 's
               6.1-3      IL - 4

    Chain 22 (IDENT)
               6.8-37     five such receptors 0 *T*-2 to be *-3 developed and tested by Receptech Corp. , a spinoff of
                          Immunex , through a proposed $ 30 million *U* initial public offering
               7.17-19    the new agents

    Chain 18 (APPOS)
        HEAD   6.20-21    Receptech Corp.
        ATTRIB 6.23-26    a spinoff of Immunex

    Chain 17 (IDENT)
               6.20-26    Receptech Corp. , a spinoff of Immunex
               7.4-5      the spinoff
               8.9-9      Receptech
